The Paris Bourse closed down 0.42% on Friday following the publication of employment figures showing a slowdown in job creation in the United States.
The Parisian odds, which had ended sharply down 1.72% Thursday after a triptych of records at the start of the year, has cd 30.18 points 7,219.48 points. Over the week, the CAC 40 index gained 0.93%.
The American economy created 199,000 jobs in December while the consensus expected almost double (440,000), but the unemployment rate nonetheless continued to decline and this, more than expected, falling 3.9% (-0.3 point percentage).
Sign of the tension that persists on the labor market, wages rose 0.6% over the last month in the United States.
Most analysts, however, believe that these elements should not cause the US Federal Reserve to change its mind, as it is preparing to raise interest rates in three months.
This somewhat muted stock market movement attests to a neutral reaction to this monthly publication which gives opposite signals with, on the one hand, disappointing job creation in December but on the other, a markedly declining unemployment rate, says Mikal Jacoby, Head of Continental Europe Brokerage at Oddo Securities.
In terms of health, we are also in a kind of half-heartedness, he underlines, with a Covid-19 pandemic which has continued its outbreak this week in the world while deaths have remained in decline.
STMicroelectronics star of the day
STMicroelectronics shares jumped 3.45% 44.38 euros. Sales of the Franco-Italian semiconductor maker STMicroelectronics rose 24.9% over 2021 as a whole to $ 12.76 billion, driven by strong global demand in its markets.
Raw materials benefit
Inflation has benefited ArcelorMittal (+ 3.40% 30.53 euros), Eramet (+ 2.88% 78.70 euros) or even TotalEnergies (+ 1.14% 46.46 euros).
Banks gutted by the rise in rates
Comparative savings booklets : 9 offers compares, up 3% yield
The titles Crdit Agricole (+ 1.01%), BNP Paribas (+ 0.48%) and Socit Gnrale (+ 1.07%) benefited from the rise in long rates on the sovereign debt market.
New partnership for Sanofi
The French laboratory Sanofi (+ 0.52% 88.60 euros) has announced that it has entered into a license and research agreement with Exscientia, a British specialist in the design of drugs using artificial intelligence, with an initial payment of 100 million of dollars.
Trigano picks up speed
The share climbed 5.83% to 183.44euros. The European leader in leisure vehicles (motorhomes, etc.) reported a 9.2% increase in turnover in the first quarter of its 2021/2022 fiscal year, but noted the still disruptive supply difficulties for his activity.